Intermittent fasting has gained widespread popularity as a dietary approach, with proponents claiming benefits ranging from weight loss to improved metabolic health. Researchers in countries such as the United States, the United Kingdom and Spain are actively investigating the scientific validity of these claims.
Intermittent fasting involves alternating periods of eating and fasting, with common methods including the 16:8 model and alternate-day fasting. Studies suggest that these approaches may improve insulin sensitivity, reduce inflammation and support weight management.
In Spain, clinical research has explored the cardiovascular benefits of intermittent fasting, while studies in the United Kingdom have focused on adherence and behavioural sustainability. In the United States, researchers are examining its potential role in preventing chronic diseases such as type 2 diabetes.
Despite promising findings, experts emphasise that intermittent fasting is not a universal solution. Its effectiveness can vary depending on individual factors, including age, sex, medical history and lifestyle. Additionally, concerns have been raised about its suitability for certain populations, such as individuals with eating disorders or metabolic conditions.
Long-term data on intermittent fasting remains limited, and further research is needed to fully understand its benefits and potential risks. As with any dietary intervention, healthcare professionals recommend personalised guidance to ensure safe and effective implementation.